News
The company, which spun out of a Korean institute, said its test has been listed at 10 leading hospitals and academic centers.
While NICE recommended the drug for patients with at least one F508del mutation, Vertex struck a reimbursement deal with NHS England for a broader population.
The firm also said it would evaluate strategic alternatives for its animal health business and close a prostate cancer vaccine trial.
An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.
The firm said the agency cited chemistry, manufacturing, and controls issues in its complete response letter, but had no concerns about product quality.
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...
The Whitrod family launched Genetic Cures for Kids in the hopes of finding a treatment for their daughter with hereditary ...
The firm will use the funds to conduct a Phase I/II trial of an adoptive cell therapy designed to activate T regulatory cells against cancer.
ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.
The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results